18.9 C
New York
Wednesday, June 17, 2026

Tag: grants

MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million

LA JOLLA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces a Standby Equity Purchase Agreement (SEPA) for up to $30 million worth of common stock over the course of 36 months.

Rubicon Organics Announces the Results of the Annual General and Special Meeting, Appoints Chair & Grants DSUs

VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis, reports the voting results from its Annual General and Special Meeting of shareholders (the “Meeting”) held earlier today.

Dolby Laboratories Reports Third Quarter 2025 Financial Results

SAN FRANCISCO, July 31, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2025. ...

Shenandoah Telecommunications Company Reports Second Quarter 2025 Results

EDINBURG, Va., July 31, 2025 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced second quarter 2025 financial and operating results.

Coveo Reports First Quarter Fiscal 2026 Financial Results

Growth rate reaccelerates to 16% for the Coveo core platform(2)Generative AI solutions drove ~50% of new business during the quarterBroadens relationship with SAP Coveo reports...

Coveo Reports First Quarter Fiscal 2026 Financial Results

Growth rate reaccelerates to 16% for the Coveo core platform(2)Generative AI solutions drove ~50% of new business during the quarterBroadens relationship with SAP Coveo reports...

Energy Transition Meets Emerging Tech on August 20th at EnerCom’s 30th Anniversary Energy Investment Conference

Landmark 30th Anniversary EnerCom Denver – The Energy Investment Conference Announces Energy Transition and Emerging Technology Session Schedule Qualified Investors and Analysts Can Register at...

ReconAfrica Provides a Corporate Update and Announces That the Kavango West 1X Well Has Started Drilling

CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) -- Reconnaissance Energy Africa Ltd. (the “Company” or “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces that the Kavango West 1X exploration well is currently drilling and provides a corporate update on ongoing operations.

Eesti Energia Group Unaudited Results for Q2 2025

Sales Revenues and Profitability

eBay Inc. Reports Second Quarter 2025 Results

Revenue of $2.7 billion, up 6% on an as-reported basis and up 4% on an FX-Neutral basisGross Merchandise Volume ("GMV") of $19.5 billion, up...

T&H Farms Sells Tax Credits from Solar Agrivoltaics Project

Transaction facilitated by Concentro FAIRMONT, N.C., July 30, 2025 /PRNewswire/ -- T&H Farms, a family-owned farm, today announced the successful sale of clean energy tax...

California education leaders unite to strengthen, transform future of teacher workforce

SACRAMENTO, Calif., July 29, 2025 /PRNewswire/ -- The California State Educator Workforce Collaborative, a first-ever partnership of 12 education agencies and institutions, today released a...

Rakovina Therapeutics Announces Stock Option Grants

VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (FSE: 7JO0) (the “Company” or “Rakovina”), a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce that its board of directors has approved the grant of an aggregate of 540,000 stock options (the “Options”) to certain consultants, employees, officers and directors of the Company pursuant to the Company’s Long Term Incentive Plan.

Cell Therapy Market to Reach USD 29.5 Billion by 2032, Growing at 21.5% CAGR | SkyQuest Technology Consulting

The cell therapy market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing demand for novel treatments,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsGrants